Patents by Inventor Steven Gareth Griffiths

Steven Gareth Griffiths has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy
    Patent number: 8956878
    Abstract: The present application is directed to a peptides comprising an a-helix forming-amino acid sequence that binds a heat shock protein. Also included is a polypeptide comprising (a) a first peptide portion that comprises an ?-helix-forming amino acid sequence that binds a heat shock protein; and (b) at least one second peptide portion comprising an antigenic amino acid sequence and/or an a-helix-stabilizing amino acid sequence that increases the interaction of the first peptide portion with the heat shock protein. The present application also includes compositions comprising the peptides and/or polypeptides of present application and uses of the peptides and/or polypeptides of the present application for fractionating substances relevant for discovery, research or clinical analysis from a biological sample and as therapeutics.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: February 17, 2015
    Assignees: Atlantic Cancer Research Institute, New England Peptide, Inc.
    Inventors: Steven Gareth Griffiths, Scott Edwin Lewis
  • POLYPEPTIDES WITH AFFINITY FOR HEAT SHOCK PROTEINS (HSPS) AND HSP ASSOCIATED COMPLEXES (HACS) AND THEIR USE IN DIAGNOSIS AND THERAPY
    Publication number: 20130243802
    Abstract: The present application is directed to a peptides comprising an a-helix forming-amino acid sequence that binds a heat shock protein. Also included is a polypeptide comprising (a) a first peptide portion that comprises an ?-helix-forming amino acid sequence that binds a heat shock protein; and (b) at least one second peptide portion comprising an antigenic amino acid sequence and/or an a-helix-stabilizing amino acid sequence that increases the interaction of the first peptide portion with the heat shock protein. The present application also includes compositions comprising the peptides and/or polypeptides of present application and uses of the peptides and/or polypeptides of the present application for fractionating substances relevant for discovery, research or clinical analysis from a biological sample and as therapeutics.
    Type: Application
    Filed: March 21, 2012
    Publication date: September 19, 2013
    Applicant: Atlantic Research Center Institute
    Inventors: Steven Gareth Griffiths, Scott Edwin Lewis
  • HSP60 from arthrobacter
    Patent number: 7803924
    Abstract: The hsp60 gene from a strain of Arthrobacter has been isolated and sequenced. The encoded protein is believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens.
    Type: Grant
    Filed: October 26, 2007
    Date of Patent: September 28, 2010
    Assignee: Novartis AG
    Inventors: Steven Gareth Griffiths, Rachael Jane Ritchie, Nathalie C. Simard
  • Vaccine against salmonid rickettsial septicaemia based on cells
    Patent number: 7707970
    Abstract: A vaccine based on live Arthrobacter cells is useful in preventing piscirickettsiosis in fish.
    Type: Grant
    Filed: November 9, 2007
    Date of Patent: May 4, 2010
    Assignee: Novartis AG
    Inventors: Kira Salonius, Steven Gareth Griffiths
  • Hsp70 from
    Patent number: 7674892
    Abstract: The hsp70 gene from an Arthrobacter species has been isolated and sequenced. The encoded protein is believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: March 9, 2010
    Assignee: Novartis AG
    Inventors: Steven Gareth Griffiths, Rachael Jane Ritchie, Nathalie C. Simard
  • Vaccine Against Salmonid Rickettsial Septicaemia Based on Arthrobacter Cells
    Publication number: 20090155313
    Abstract: A vaccine based on live Arthrobacter cells is useful in preventing piscirickettsiosis in fish.
    Type: Application
    Filed: November 9, 2007
    Publication date: June 18, 2009
    Inventors: Kira Salonius, Steven Gareth Griffiths
  • HSP60 FROM ARTHROBACTER
    Publication number: 20080287664
    Abstract: The hsp60 gene from a strain of Arthrobacter has been isolated and sequenced. The encoded protein is believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens.
    Type: Application
    Filed: October 26, 2007
    Publication date: November 20, 2008
    Inventors: Steven Gareth Griffiths, Rachael Jane Ritchie, Nathalie C. Simard
  • Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
    Patent number: 7302913
    Abstract: A vaccine based on live Arthrobacter cells is useful in preventing piscirickettsiosis in fish.
    Type: Grant
    Filed: February 14, 2005
    Date of Patent: December 4, 2007
    Assignee: Novartis AG
    Inventors: Kira Salonius, Steven Gareth Griffiths
  • Renibacterium salmoninarum vaccine
    Patent number: 6913754
    Abstract: The invention provides and immune stimulating agent or vaccine directed to Renibacterium salmoninarum comprising a live non-virulent culture of an Arthrobacter strain based on, derived from or substantially homologous with strain RSxII as deposited as ATCC 55921. The culture may be presented in lyophilized form with a sterile diluent.
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: July 5, 2005
    Assignee: Novartis AG
    Inventors: Steven Gareth Griffiths, Kira Salonius
  • Renibacterium salmoninarum vaccine
    Patent number: 6627203
    Abstract: The invention provides an immune stimulating agent or vaccine directed to Renibacterium salmoninarum comprising a live non-virulent culture of an Arthrobacter strain based on, derived from or substantially homologous with strain RSxII as deposited as ATCC 55921. The culture may be presented in lyophilized form with a sterile diluent.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: September 30, 2003
    Assignee: Aqua Health (Europe) Limited
    Inventors: Steven Gareth Griffiths, Kira Salonius